AbbVie (ABBV) Other Accumulated Expenses (2012 - 2015)

AbbVie has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $2.5 billion for Q4 2015.

• In Q4 2015, Other Accumulated Expenses rose 31.54% year-over-year to $2.5 billion; the TTM figure through Dec 2015 stood at $2.5 billion (up 31.54% YoY), while the FY2015 annual figure was $2.5 billion, up 31.54% from the prior year.
• Other Accumulated Expenses improved to $2.5 billion in Q4 2015, from $1.9 billion in the prior quarter.
• Over the last five years, Other Accumulated Expenses for ABBV reached as high as $2.5 billion in Q4 2015 and fell as low as $1.5 billion in Q4 2013.
• The 4-year median for Other Accumulated Expenses is $1.8 billion (2012), against an average of $1.9 billion.
• Annual changes were most pronounced in 2013 — Other Accumulated Expenses slipped 10.88% — and 2015, when it jumped 31.54%.
• A 4-year view of Other Accumulated Expenses shows it stood at $1.7 billion in 2012, then declined by 10.88% to $1.5 billion in 2013, then climbed by 26.32% to $1.9 billion in 2014, then jumped by 31.54% to $2.5 billion in 2015.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.5 billion, $1.9 billion, and $1.5 billion for Q4 2015, Q4 2014, and Q4 2013 respectively.